InDex Pharmaceuticals Holding AB INDEX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.35
- Day Range
- SEK 0.36–0.37
- 52-Week Range
- SEK 0.20–0.93
- Bid/Ask
- SEK 0.37 / SEK 0.37
- Market Cap
- SEK 196.03 Mil
- Volume/Avg
- 4.4 Mil / 2.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
InDex Pharmaceuticals Holding AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The company's main asset is the drug candidate cobitolimod, which is being evaluated in the phase III study as a treatment for moderate to severe ulcerative colitis - a disabling, chronic inflammation of the colon. It has also developed a platform of patent-protected substances, so-called DNA-based Immunomodulatory Sequences, with the potential to be used in the treatment of various immunological diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 7
- Website
- https://www.indexpharma.com
Valuation
|
Metric
|
INDEX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.82 |
Price/Sales | 2.01 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
INDEX
|
|---|---|
Quick Ratio | 5.03 |
Current Ratio | 5.04 |
Interest Coverage | −472.98 |
Quick Ratio
INDEX
Profitability
|
Metric
|
INDEX
|
|---|---|
Return on Assets (Normalized) | −26.53% |
Return on Equity (Normalized) | −29.92% |
Return on Invested Capital (Normalized) | −33.43% |
Return on Assets
INDEX
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Syvqhxvl | Rgzqv | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Crdscfgy | Bffmgyr | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Nfltdbkcp | Pdvmgk | $97.8 Bil | |
MRNA
| Moderna Inc | Qwxptsgy | Mkjl | $41.3 Bil | |
ARGX
| argenx SE ADR | Nqdtdzwfk | Wph | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Jjfxphpx | Gnmh | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Jxscmtsq | Yrjnw | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hdvbxwvs | Dpcjrz | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Blfcjldvy | Mgbtbch | $12.5 Bil | |
INCY
| Incyte Corp | Vzdkkqm | Bfmvn | $11.6 Bil |